Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFα signaling
Open Access
- 1 November 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 22 (11) , 1843-1851
- https://doi.org/10.1093/carcin/22.11.1843
Abstract
Rodents exposed to peroxisome proliferator xenobiotics respond with marked increases in hepatocellular replication and growth that results in tumor formation. Recently, tumor necrosis factor-α (TNFα) was proposed as the central mediator of this maladaptive response. To define the role of TNFα signaling in hepatocellular growth induced by peroxisome proliferators we administered three daily gavage doses of the potent peroxisome proliferator, Wy-14 643, to mice nullizygous for TNF-receptor I (TNFR1), TNFR2, or both receptors. We demonstrate here that regardless of genotype the mice responded with almost identical increases in liver to body weight ratios and hepatocyte proliferation. Lacking evidence that TNFα signaling mediates these effects, we then examined the possible contribution of alternative cytokine pathways. Semi-quantitative, reverse transcriptase polymerase chain reaction analysis revealed that wild type mice acutely exposed to Wy-14 643 had increased hepatic expression of Il1β, Il1r1, Hnf4, and Stat3 genes. Moreover, hepatic adenomas from mice chronically exposed to Wy-14 643 had increased expression of Il1β, Il1r1, Il6, and Pparγ1. Expression of Il1α, Tnfα, Tnfr1, Tnfr2, Pparα, or C/ebpα was not altered by acute Wy-14 643 exposure or in adenomas induced by Wy-14643. These data suggest that the hepatic mitogenesis and carcinogenesis associated with peroxisome proliferator exposure is not mediated via TNFα but instead may involve an alternative pathway requiring IL1β and IL6.Keywords
This publication has 66 references indexed in Scilit:
- Apoptosis, mitosis and cyclophilin-40 expression in regressing peroxisome proliferator-induced adenomasCarcinogenesis: Integrative Cancer Research, 2000
- Central Role of Peroxisome Proliferator–Activated Receptors in the Actions of Peroxisome ProliferatorsAnnual Review of Pharmacology and Toxicology, 2000
- Hepatic expression of acute-phase protein genes during carcinogenesis induced by peroxisome proliferatorsMolecular Carcinogenesis, 1999
- Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643Carcinogenesis: Integrative Cancer Research, 1997
- Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regressionHepatology, 1997
- Targeted Disruption of the α Isoform of the Peroxisome Proliferator-Activated Receptor Gene in Mice Results in Abolishment of the Pleiotropic Effects of Peroxisome ProliferatorsMolecular and Cellular Biology, 1995
- Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced HepatocarcinogenesisHuman & Experimental Toxicology, 1994
- Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643Carcinogenesis: Integrative Cancer Research, 1994
- Biochemical Mechanisms of Induction of Hepatic Peroxisome ProliferationAnnual Review of Pharmacology and Toxicology, 1989
- Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogensNature, 1980